Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Former Medtronic exec joins CSI to push peripheral artery disease therapy

This article was originally published in Clinica

Executive Summary

Cardiovascular Systems (CSI), the developer of the Diamondback 360° orbital peripheral artery disease (PAD) system, has appointed Kevin Kenny to the new role of executive vice-president of sales and marketing. Prior to joining CSI, Mr Kenny spent nearly 10 years at Medtronic's Spine and Biologics division where he held various senior roles including vice-president of US sales and, most recently, executive consultant for special projects. Mr Kenny will apply his 20-plus years' sales experience to help push commercialisation of CSI's latest orbital PAD system, Stealth 360°, which was cleared by the FDA in March. The St Paul, Minnesota firm's PAD systems treat calcified and fibrotic plaque in arterial vessels throughout the leg within a few minutes.

You may also be interested in...

Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?

Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.

Roche Dx' EMEA Head To Take Charge After Diggelmann Departs

Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.

Nose For A Good Tech? Philips Adds Nasal Alar Pulse Oximetry To Monitoring Portfolio

Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts